The INSPIRE Pipeline™ Shield Post Approval Study is looking at how well a special device called the Pipeline™ Flex Embolization Device with Shield Technology™ works for patients with intracranial aneurysms. An intracranial aneurysm is a bulge in a blood vessel in the brain that can be dangerous if it bursts. The study is happening in the United States and will use real-world data to see if the device is safe and effective. This study is observational, which means doctors will watch and record how the device works during regular care, without changing any treatments.

Key Points to Consider:

• The study will take place across multiple centers in the U.S., and no additional visits are required beyond regular care.
• Participants must give permission to use their medical information and follow study guidelines.
• Pregnant or breastfeeding women cannot join the study, and participants should not join other studies that might affect results.